SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Linda A. Parker, Micah J. Niphakis, Rachel Downey, Cheryl L. Limebeer, Erin M. Rock, Martin A. Sticht, Heather Morris, Rehab A. Abdullah, Aron H. Lichtman, Benjamin F. Cravatt, Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus, Psychopharmacology, 2015, 232, 3, 583

    CrossRef

  2. 2
    Teuta Zoto, Saadettin Kilickap, Umit Yasar, Ismail Celik, Atilla Bozkurt, Melih Onder Babaoglu, Improved Anti-Emetic Efficacy of 5-HT3 Receptor Antagonists in Cancer Patients with Genetic Polymorphisms of ABCB1 (MDR1) Drug Transporter, Basic & Clinical Pharmacology & Toxicology, 2015, 116, 2
  3. 3
    Weiheng Hu, Jian Fang, Jun Nie, Ling Dai, Xiaoling Chen, Jie Zhang, Xiangjuan Ma, Guangming Tian, Jindi Han, Addition of aprepitant improves protection against cisplatin-induced emesis when a conventional anti-emetic regimen fails, Cancer Chemotherapy and Pharmacology, 2014, 73, 6, 1129

    CrossRef

  4. 4
    Erin M. Rock, Cheryl L. Limebeer, Linda A. Parker, Anticipatory nausea in animal models: a review of potential novel therapeutic treatments, Experimental Brain Research, 2014, 232, 8, 2511

    CrossRef

  5. 5
    Stefania Russo, Marika Cinausero, Lorenzo Gerratana, Claudia Bozza, Donatella Iacono, Pamela Driol, Laura Deroma, Roberta Sottile, Gianpiero Fasola, Fabio Puglisi, Factors affecting patient's perception of anticancer treatments side-effects: an observational study, Expert Opinion on Drug Safety, 2014, 13, 2, 139

    CrossRef

  6. 6
    Sita S. Withers, Philip H. Kass, Carlos O. Rodriguez, Katherine A. Skorupski, Danielle O’Brien, Teri A. Guerrero, Kristen D. Sein, Robert B. Rebhun, Fasting Reduces the Incidence of Delayed-Type Vomiting Associated with Doxorubicin Treatment in Dogs with Lymphoma, Translational Oncology, 2014, 7, 3, 377

    CrossRef

  7. 7
    Lee Schwartzberg, Sally Y. Barbour, Gary R. Morrow, Gianluca Ballinari, Michael D. Thorn, David Cox, Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV), Supportive Care in Cancer, 2014, 22, 2, 469

    CrossRef

  8. 8
    Keith A. Sharkey, Nissar A. Darmani, Linda A. Parker, Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system, European Journal of Pharmacology, 2014, 722, 134

    CrossRef

  9. 9
    Katsunobu Oyama, Sachio Fushida, Masahide Kaji, Toshiya Takeda, Shinichi Kinami, Yasuo Hirono, Katsuhiro Yoshimoto, Kazuhisa Yabushita, Hisashi Hirosawa, Yuki Takai, Tatsuo Nakano, Hironobu Kimura, Toshiaki Yasui, Atsushi Tsuneda, Tomoya Tsukada, Jun Kinoshita, Takashi Fujimura, Tetsuo Ohta, Aprepitant plus granisetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin, Journal of Gastroenterology, 2013, 48, 11, 1234

    CrossRef

  10. 10
    Daiki TSUJI, Yong-Il KIM, Hidenori NAKAMICHI, Takashi DAIMON, Kaori SUWA, Yutaro IWABE, Hideki HAYASHI, Kazuyuki INOUE, Masayuki YOSHIDA, Kunihiko ITOH, Association of ABCB1 Polymorphisms with the Antiemetic Efficacy of Granisetron plus Dexamethasone in Breast Cancer Patients, Drug Metabolism and Pharmacokinetics, 2013, 28, 4, 299

    CrossRef

  11. 11
    Jun-zhong Sun, Xiao-qin Ha, Li-ming Zhang, Hai-bin Wang, Hong-wei Wang, Hai-feng Duan, Attenuated Salmonella typhimurium carrying the hepatocyte growth factor and keratinocyte growth factor genes repairs gastrointestinal mucosal damage caused by chemotherapy, Medical Oncology, 2013, 30, 1

    CrossRef

  12. 12
    D Bolognini, EM Rock, NL Cluny, MG Cascio, CL Limebeer, M Duncan, CG Stott, FA Javid, LA Parker, RG Pertwee, Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation, British Journal of Pharmacology, 2013, 168, 6
  13. 13
    EM Rock, LA Parker, Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats, British Journal of Pharmacology, 2013, 169, 3
  14. 14
    G. Camus, V. Jandard, A.-G. Caffin, X. Bohand, Effets indésirables des médicaments anticancéreux utilisés en pneumologie, Revue des Maladies Respiratoires Actualités, 2013, 5, 5, 367

    CrossRef

  15. You have free access to this content15
    Guy H. Montgomery, Julie B. Schnur, Kate Kravits, Hypnosis for cancer care: Over 200 years young, CA: A Cancer Journal for Clinicians, 2013, 63, 1
  16. 16
    Melissa Y.T. Chan, Shelley K. Cross-Mellor, Martin Kavaliers, Klaus-Peter Ossenkopp, Impairment of lithium chloride-induced conditioned gaping responses (anticipatory nausea) following immune system stimulation with lipopolysaccharide (LPS) occurs in both LPS tolerant and LPS non-tolerant rats, Brain, Behavior, and Immunity, 2013, 27, 123

    CrossRef

  17. 17
    Ikuo Sekine, Yoshihiko Segawa, Kaoru Kubota, Toshiaki Saeki, Risk factors of chemotherapy-induced nausea and vomiting: Index for personalized antiemetic prophylaxis, Cancer Science, 2013, 104, 6
  18. 18
    J. García Gómez, M. E. Pérez López, M. Alonso Bermejo, Y. Escobar Álvarez, J. García Mata, SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013, Clinical and Translational Oncology, 2013, 15, 12, 1030

    CrossRef

  19. 19
    E.M. Rock, L.A. Parker, Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid, Pharmacology Biochemistry and Behavior, 2013, 111, 84

    CrossRef

  20. 20
    Rudolph M. Navari, Cindy K. Nagy, Sarah E. Gray, The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, Supportive Care in Cancer, 2013, 21, 6, 1655

    CrossRef

  21. 21
    Paul J. E. Miller, Sanjeev Balu, Deborah Buchner, Mark S. Walker, Edward J. Stepanski, Lee S. Schwartzberg, Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer, Journal of Medical Economics, 2013, 16, 10, 1179

    CrossRef

  22. 22
    Rachel Whelan, Christian C. Apfel, Pharmacology and Physiology for Anesthesia, 2013,

    CrossRef

  23. 23
    P. Fernández-Ortega, M. T. Caloto, E. Chirveches, R. Marquilles, J. San Francisco, A. Quesada, C. Suárez, I. Zorrilla, J. Gómez, P. Zabaleta, G. Nocea, A. Llombart-Cussac, Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life, Supportive Care in Cancer, 2012, 20, 12, 3141

    CrossRef

  24. 24
    Daiki Tsuji, Yong-Il Kim, Keisei Taku, Shigeru Nakagaki, Yoshito Ikematsu, Hiromi Tsubota, Masato Maeda, Naoya Hashimoto, Masayuki Kimura, Takashi Daimon, Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial, Supportive Care in Cancer, 2012, 20, 5, 1057

    CrossRef

  25. 25
    Julie L. Ryan, Charles E. Heckler, Joseph A. Roscoe, Shaker R. Dakhil, Jeffrey Kirshner, Patrick J. Flynn, Jane T. Hickok, Gary R. Morrow, Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients, Supportive Care in Cancer, 2012, 20, 7, 1479

    CrossRef

  26. 26
    Olivier Mir, Jean-Philippe Durand, Pascaline Boudou-Rouquette, Julie Giroux, Romain Coriat, Anatole Cessot, Stanislas Ropert, François Goldwasser, Raphaël Gaillard, Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case–control study, Supportive Care in Cancer, 2012, 20, 9, 2235

    CrossRef

  27. 27
    Shota Hamada, Shiro Hinotsu, Katsuhito Hori, Hiroshi Furuse, Takehiro Oikawa, Junichi Kawakami, Seiichiro Ozono, Hideyuki Akaza, Koji Kawakami, The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study, Supportive Care in Cancer, 2012, 20, 4, 813

    CrossRef

  28. 28
    Klaus-Peter Ossenkopp, Elissa Biagi, Caylen J. Cloutier, Melissa Y.T. Chan, Martin Kavaliers, Shelley K. Cross-Mellor, Acute corticosterone increases conditioned spontaneous orofacial behaviors but fails to influence dose related LiCl-induced conditioned “gaping” responses in a rodent model of anticipatory nausea, European Journal of Pharmacology, 2011, 660, 2-3, 358

    CrossRef

  29. 29
    Jason M. Jones, Rui Qin, Aditya Bardia, Breanna Linquist, Sherry Wolf, Charles L. Loprinzi, Antiemetics for Chemotherapy-Induced Nausea and Vomiting Occurring Despite Prophylactic Antiemetic Therapy, Journal of Palliative Medicine, 2011, 14, 7, 810

    CrossRef

  30. 30
    Margarita Majem, Ma Estela Moreno, Núria Calvo, Anna Feliu, Javier Pérez, Ma Antonia Mangues, Agustí Barnadas, Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists, Supportive Care in Cancer, 2011, 19, 12, 1983

    CrossRef

  31. You have free access to this content31
    Linda A Parker, Erin M Rock, Cheryl L Limebeer, Regulation of nausea and vomiting by cannabinoids, British Journal of Pharmacology, 2011, 163, 7
  32. 32
    Carlo Pirri, Paul Katris, James Trotter, Evan Bayliss, Robert Bennett, Peter Drummond, Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study, Supportive Care in Cancer, 2011, 19, 10, 1549

    CrossRef

  33. 33
    Kouichi Yamamoto, Keiko Asano, Naoki Matsukawa, Masahiro Imaizumi, Atsushi Yamatodani, Time-course analysis of pica in rats using an automatic feeding monitoring system, Journal of Pharmacological and Toxicological Methods, 2011, 63, 1, 30

    CrossRef

  34. 34
    Joseph A. Roscoe, Michael O'Neill, Pascal Jean-Pierre, Charles E. Heckler, Ted J. Kaptchuk, Peter Bushunow, Michelle Shayne, Alissa Huston, Raman Qazi, Brian Smith, An Exploratory Study on the Effects of an Expectancy Manipulation on Chemotherapy-Related Nausea, Journal of Pain and Symptom Management, 2010, 40, 3, 379

    CrossRef

  35. 35
    Mi Rim Choi, Cynthia Jiles, Nita L. Seibel, Aprepitant Use in Children, Adolescents, and Young Adults for the Control of Chemotherapy-Induced Nausea and Vomiting (CINV), Journal of Pediatric Hematology/Oncology, 2010, 32, 7, e268

    CrossRef

  36. 36
    Cesare Gridelli, Amin M. Haiderali, Mark W. Russo, Linda M. Blackburn, Konstantinos Lykopoulos, Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy, Supportive Care in Cancer, 2010, 18, 11, 1437

    CrossRef

  37. 37
    J. Zheng, G. Wang, G. Y. Yang, D. Wang, X. Luo, C. Chen, Z. Zhang, Q. Li, W. Xu, Z. Li, D. Wang, Induction Chemotherapy with Nedaplatin with 5-FU Followed by Intensity-modulated Radiotherapy Concurrent with Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma, Japanese Journal of Clinical Oncology, 2010, 40, 5, 425

    CrossRef

  38. 38
    Joseph A. Roscoe, Gary R. Morrow, Ben Colagiuri, Charles E. Heckler, Bryan D. Pudlo, Lauren Colman, Karen Hoelzer, Andrew Jacobs, Insight in the prediction of chemotherapy-induced nausea, Supportive Care in Cancer, 2010, 18, 7, 869

    CrossRef

  39. 39
    Rudolph M Navari, Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer, Future Oncology, 2010, 6, 7, 1073

    CrossRef

  40. 40
    Ben Colagiuri, Robert Zachariae, Patient Expectancy and Post-chemotherapy Nausea: A Meta-analysis, Annals of Behavioral Medicine, 2010, 40, 1, 3

    CrossRef

  41. 41
    Jesús García Gómez, M. Eva Pérez López, Jesús García Mata, Dolores Isla Casado, SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy, Clinical and Translational Oncology, 2010, 12, 11, 770

    CrossRef

  42. 42
    Ilana M. Braun, William F. Pirl, Donna B. Greenberg, Massachusetts General Hospital Handbook of General Hospital Psychiatry, 2010,

    CrossRef

  43. 43
    Paul J. Hesketh, Jerry Younger, Pedro Sanz-Altamira, Melissa Hayden, Julie Bushey, Brian Trainor, Michael Krentzin, Peter Nowd, Konstantinos Arnaoutakis, Ann M. Hesketh, Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide, Supportive Care in Cancer, 2009, 17, 8, 1065

    CrossRef

  44. 44
    José Dinis, Tami Wisniewski, António Moreira, João Raposo, Larry Ma, Thomas A Burke, Chemotherapy-induced nausea and vomiting in Portugal: incidence versus healthcare provider estimations and effect on quality of life, Therapy, 2009, 6, 4, 595

    CrossRef

  45. 45
    Bruce A. Feinberg, James Gilmore, Sally Haislip, Tom Gondesen, Mansoor N. Saleh, Wendy Hawke Lenz, Data-driven medical decision-making in managing chemotherapy-induced nausea and vomiting, Community Oncology, 2009, 6, 2, 62

    CrossRef

  46. 46
    Kouichi Yamamoto, Sze Wa Chan, John A. Rudd, Ge Lin, Keiko Asano, Atsushi Yamatodani, Involvement of Hypothalamic Glutamate in Cisplatin-Induced Emesis in Suncus murinus (House Musk Shrew), Journal of Pharmacological Sciences, 2009, 109, 4, 631

    CrossRef

  47. 47
    Lily P.H. Yang, Lesley J. Scott, Palonosetron, Drugs, 2009, 69, 16, 2257

    CrossRef

  48. 48
    Mitsue Saito, Kenjiro Aogi, Ikuo Sekine, Hirohisa Yoshizawa, Yasuhiro Yanagita, Hiroshi Sakai, Kenichi Inoue, Chiyoe Kitagawa, Takashi Ogura, Shoichi Mitsuhashi, Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial, The Lancet Oncology, 2009, 10, 2, 115

    CrossRef

  49. 49
    Rudolph M Navari, Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist, Expert Opinion on Drug Metabolism & Toxicology, 2009, 5, 12, 1577

    CrossRef

  50. 50
    Rudolph M. Navari, Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting, Drugs, 2009, 69, 5, 515

    CrossRef

  51. 51
    L.A. Parker, C.L. Limebeer, E.M. Rock, D.L. Litt, M. Kwiatkowska, D. Piomelli, The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew), Physiology & Behavior, 2009, 97, 1, 121

    CrossRef

  52. 52
    Sangchoon Jeon, Charles W. Given, Alla Sikorskii, Barbara Given, The Utility of Screening in the Design of Trials for Symptom Management in Cancer, Journal of Pain and Symptom Management, 2009, 38, 4, 606

    CrossRef

  53. 53
    Christina K. Ullrich, Charles B. Berde, Amy Louise Billett, Oncology of Infancy and Childhood, 2009,

    CrossRef

  54. 54
    A. Molassiotis, M. P. Saunders, J. Valle, G. Wilson, P. Lorigan, A. Wardley, E. Levine, R. Cowan, J. Loncaster, C. Rittenberg, A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre, Supportive Care in Cancer, 2008, 16, 2, 201

    CrossRef

  55. 55
    Sarah G. Brearley, Caroline V. Clements, Alex Molassiotis, A review of patient self-report tools for chemotherapy-induced nausea and vomiting, Supportive Care in Cancer, 2008, 16, 11, 1213

    CrossRef

  56. 56
    Paul J. Hesketh, Chemotherapy-Induced Nausea and Vomiting, New England Journal of Medicine, 2008, 358, 23, 2482

    CrossRef

  57. 57
    Cheryl L. Limebeer, Jon P. Krohn, Shelley Cross-Mellor, Devin E. Litt, Klaus-Peter Ossenkopp, Linda A. Parker, Exposure to a context previously associated with nausea elicits conditioned gaping in rats: A model of anticipatory nausea, Behavioural Brain Research, 2008, 187, 1, 33

    CrossRef

  58. 58
    Simon JP Van Belle, Veronique Cocquyt, Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting, Expert Opinion on Pharmacotherapy, 2008, 9, 18, 3261

    CrossRef

  59. 59
    Ben Colagiuri, Joseph A. Roscoe, Gary R. Morrow, James N. Atkins, Jeffrey K. Giguere, Lauren K. Colman, How do patient expectancies, quality of life, and postchemotherapy nausea interrelate?, Cancer, 2008, 113, 3
  60. 60
    Ana Carolina Sepúlveda-Vildósola, Yadira Betanzos-Cabrera, Graciela Gascón Lastiri, Hugo Rivera-Márquez, Miguel Angel Villasis-Keever, Volkmar Wanzke del Angel, Fernando Cerecedo Díaz, Enrique López-Aguilar, Palonosetron Hydrochloride Is an Effective and Safe Option to Prevent Chemotherapy-induced Nausea and Vomiting in Children, Archives of Medical Research, 2008, 39, 6, 601

    CrossRef

  61. 61
    Donna B. Greenberg, William F. Pirl, Massachusetts General Hospital Comprehensive Clinical Psychiatry, 2008,

    CrossRef

  62. 62
    Lorenzo Cohen, Carl A. de Moor, Peter Eisenberg, Eileen E. Ming, Henry Hu, Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settings, Supportive Care in Cancer, 2007, 15, 5, 497

    CrossRef

  63. 63
    Sara C. Higgins, Guy H. Montgomery, Dana H. Bovbjerg, Distress before chemotherapy predicts delayed but not acute nausea, Supportive Care in Cancer, 2007, 15, 2, 171

    CrossRef

  64. 64
    Florian Lordick, Birgit Ehlken, Angela Ihbe-Heffinger, Karin Berger, Karl J. Krobot, James Pellissier, Glenn Davies, Robert Deuson, Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany, European Journal of Cancer, 2007, 43, 2, 299

    CrossRef

  65. 65
    Doranne L. Hilarius, Paul H.A.M. Kloeg, Symone B. Detmar, Martin J. Muller, Neil K. Aaronson, Level of agreement between patient self-report and observer ratings of health-related quality of life communication in oncology, Patient Education and Counseling, 2007, 65, 1, 95

    CrossRef

  66. 66
    Hitoshi KAWAZOE, Yoshiharu TAKIGUCHI, Hiroaki TANAKA, Chiaki DOI, Noriyasu FUKUOKA, Nobuhiro KANAJI, Shuji BANDOH, Toshihiko ISHIDA, Hitoshi HOUCHI, Preventive Effects of Low-dose Dexamethasone for Delayed Adverse Events Induced by Carboplatin-based Combination Chemotherapy, YAKUGAKU ZASSHI, 2007, 127, 6, 1001

    CrossRef

  67. 67
    Alexander Molassiotis, Peter A. Coventry, Carrie T. Stricker, Caroline Clements, Beth Eaby, Luke Velders, Cynthia Rittenberg, Richard J. Gralla, Validation and Psychometric Assessment of a Short Clinical Scale to Measure Chemotherapy-Induced Nausea and Vomiting: The MASCC Antiemesis Tool, Journal of Pain and Symptom Management, 2007, 34, 2, 148

    CrossRef

  68. 68
    Mark T. Holdsworth, Dennis W. Raisch, Jami Frost, Acute and delayed nausea and emesis control in pediatric oncology patients, Cancer, 2006, 106, 4
  69. 69
    Karin Oechsle, Martin R. M&uuml;ller, J&ouml;rg T. Hartmann, Lothar Kanz, Carsten Bokemeyer, Aprepitant as Salvage Therapy in Patients with Chemotherapy-Induced Nausea and Emesis Refractory to Prophylaxis with 5-HT<sub>3</sub> Antagonists and Dexamethasone, Onkologie, 2006, 29, 12, 557

    CrossRef

  70. 70
    Rudolph M Navari, Paula S Province, Emerging drugs for chemotherapy-induced emesis, Expert Opinion on Emerging Drugs, 2006, 11, 1, 137

    CrossRef

  71. 71
    Edward B. Rubenstein, Barbara S. Slusher, Camilo Rojas, Rudolph M. Navari, New Approaches to Chemotherapy-Induced Nausea and Vomiting, The Cancer Journal, 2006, 12, 5, 341

    CrossRef

  72. 72
    Rudolph M. Navari, Ondansetron, prochlorperazine, and dexamethasone have similar effects on prevention of delayed chemotherapy-induced nausea and vomiting, Cancer Treatment Reviews, 2006, 32, 1, 50

    CrossRef

  73. 73
    Rudolph M Navari, Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist, Future Oncology, 2006, 2, 5, 591

    CrossRef

  74. 74
    Jane T Hickok, Joseph A Roscoe, Gary R Morrow, Christopher W Bole, Hongwei Zhao, Karen L Hoelzer, Shaker R Dakhil, Timothy Moore, Tom R Fitch, 5-hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial, The Lancet Oncology, 2005, 6, 10, 765

    CrossRef

  75. 75
    Rudolph M. Navari, Lawrence H. Einhorn, Steven D. Passik, Patrick J. Loehrer, Cynthia Johnson, M. L. Mayer, J. McClean, Jake Vinson, W. Pletcher, A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group study, Supportive Care in Cancer, 2005, 13, 7, 529

    CrossRef

  76. 76
    Joseph A. Roscoe, Sara E. Matteson, Gary R. Morrow, Jane T. Hickok, Peter Bushunow, Jennifer Griggs, Raman Qazi, Brian Smith, Zachary Kramer, Julia Smith, Acustimulation Wrist Bands Are Not Effective for the Control of Chemotherapy-Induced Nausea in Women with Breast Cancer, Journal of Pain and Symptom Management, 2005, 29, 4, 376

    CrossRef

  77. 77
    Matti Aapro, Judi Johnson, Chemotherapy-Induced Emesis in Elderly Cancer Patients: The Role of 5-HT<sub>3</sub>-Receptor Antagonists in the First 24 Hours, Gerontology, 2005, 51, 5, 287

    CrossRef

  78. 78
    Jean Lachaine, Louise Yelle, Leonard Kaizer, Anick Dufour, Sean Hopkins, Robert Deuson, Chemotherapy-Induced Emesis: Quality of Life and Economic Impact in the Context of Current Practice in Canada, Supportive Cancer Therapy, 2005, 2, 3, 181

    CrossRef

  79. 79
    Giuseppe Riezzo, Caterina Clemente, Silvana Leo, Francesco Russo, The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms, Journal of Gastroenterology, 2005, 40, 12, 1107

    CrossRef

  80. 80
    Maurie Markman, 2005,

    CrossRef

  81. 81
    Rudolph M Navari, Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting, Expert Review of Anticancer Therapy, 2004, 4, 5, 715

    CrossRef

  82. 82
    Kouichi Yamamoto, Man P. Ngan, Noriaki Takeda, Atsushi Yamatodani, John A. Rudd, Differential activity of drugs to induce emesis and pica behavior in Suncus murinus (house musk shrew) and rats, Physiology & Behavior, 2004, 83, 1, 151

    CrossRef

  83. 83
    Steven M. Grunberg, Robert R. Deuson, Panagiotis Mavros, Olga Geling, Mogens Hansen, Giorgio Cruciani, Bruno Daniele, Gerard De Pouvourville, Edward B. Rubenstein, Gedske Daugaard, Incidence of chemotherapy-induced nausea and emesis after modern antiemetics, Cancer, 2004, 100, 10
  84. 84
    Maurie Markman, Toxicities of the platinum antineoplastic agents, Expert Opinion on Drug Safety, 2003, 2, 6, 597

    CrossRef

  85. 85
    Ivo W Tremont-Lukats, Eduardo Bruera, Jesús González-Barboteo, Neurokinin-1 receptor antagonists for prevention of chemotherapy-related nausea and vomiting in adults, The Cochrane Library,